Bioventix PLC | Ownership
Companies that own Bioventix PLC
Hargreaves Lansdown Stockbrokers Ltd.
591,000
11.5%
20,000
0.14%
06/01/2018
Castlefield Investment Partners LLP
575,000
11.19%
160,000
14.06%
06/26/2018
Sanford DeLand Asset Management Ltd.
525,000
10.21%
41,000
4.05%
06/01/2018
Miton Asset Management Ltd.
508,135
9.89%
-54,500
0.52%
05/03/2018
Hargreave Hale Ltd.
328,500
6.39%
70,903
0.15%
09/18/2017
Henderson Global Investors Ltd.
252,041
4.9%
-227,740
0.01%
07/26/2016
Jupiter Asset Management Ltd.
200,000
3.89%
30,000
0.03%
02/28/2018
Hargreaves Lansdown Asset Management Ltd.
159,000
3.09%
13,000
0.09%
06/01/2018
Wasatch Advisors, Inc.
151,350
2.94%
-121,400
0.04%
12/28/2016
Lazard Frères Gestion SAS
142,390
2.77%
0
0.08%
03/29/2018
| Address |
7 Romans Business Park
Farnham Surrey GU9 7SX
United Kingdom
|
|
Employees
|
- |
| Website |
http://bioventix.com |
| Updated |
07/08/2019 |
| Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom. |
